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Background: Little is known about the targets and expectations of practicing nephrologists with regard to timing
of preemptive AV access surgery and how these relate to actual observed practice patterns in clinical care.
Methods: We administered a 8-question survey to assess nephrologists’ expectations for preemptive vascular
access placement to 53 practicing nephrologists in California. We performed a retrospective chart review of 116
patients who underwent preemptive vascular access placement at a large academic medical center and examined
progression to ESRD.
Results: According to our survey of nephrologists, most aimed to have preemptive vascular access created about
6 months prior to start of ESRD or when the chances of ESRD within the next year is two-thirds or greater. The
estimated GFR level at which they believe match these conditions is approximately 18 ml/min/1.73 m2. Among the
116 patients with CKD who underwent preemptive vascular access creation, the mean estimated GFR at the time of
access creation was 16.1 (6.8) ml/min/1.73 m2. Only 57 out of the 116 patients (49.1%) patients initiated
maintenance HD within 1 year after surgery.
Conclusions: In our study, most nephrologists aim for preemptive vascular access surgery approximately 6 months
prior to the start of HD. However in fact, only approximately 50% of patients who underwent preemptive vascular
access surgery started HD within 1 year. Better tools are needed to predict the natural history of advanced CKD.
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Optimal education regarding different renal replacement
modalities and timely preparation for end-stage renal
disease (ESRD) treatment are widely accepted to be
among most important benefits conferred by early referral
of chronic kidney disease (CKD) patients to nephrologists.
For patients who are not candidates for preemptive
kidney transplant and who elect eventual hemodialysis
(HD), a cornerstone intervention is preemptive surgery
for arteriovenous (AV) fistula. Numerous studies have
shown that incident ESRD patients who initiate HD
with a functioning AV fistula fare better, especially
compared with their counterparts who initiate HD with a* Correspondence: nisha.bansal@ucsf.edu
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reproduction in any medium, provided the ortunneled catheter [1,2]. National initiatives such as Fistula
First promote preemptive creation of AV fistulae [3].
Unfortunately, existing guidelines regarding optimal
timing for preemptive vascular access creation are not
based on high quality evidence and provide conflicting
recommendations [4]. For example, the latest Society of
Vascular Surgery guidelines recommend that “patients with
advanced CKD disease (late stage 4, MDRD< 20-25 mL/
min) who have elected HD as their choice of renal
replacement therapy be referred to an access surgeon in
order to evaluate and plan construction of AV access…(…
very low-quality evidence)” [5]. The Canadian Society of
Nephrology urge establishment of “AV fistulae when the
patient has an estimated GFR of 15 to 20 ml/min and
progressive kidney disease (Grade D, opinion)” [6,7]. The
2001 National Kidney Foundation KDOQI guidelines
stated that patient “with chronic kidney disease should beLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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Figure 1 Outcomes after preemptive vascular access placement
among 116 adults with advanced chronic kidney disease.
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AV fistula when their creatinine clearance is < 25 mL/min,
their serum creatinine level is >4 mg/dL, or within
1 year of an anticipated need for HD… (Opinion)” [8].
This was subsequently revised in 2006 without evidential
justification to: “A fistula should be placed at least
6 months before the anticipated start of HD treatments.
This timing allows for access evaluation and additional
time for revision to ensure a working fistula is available at
initiation of HD therapy (B)” [9].
In an ideal world, guidelines regarding optimal timing
of AV access surgery and physicians’ recommendation to
patients in this arena should be grounded in a thorough
understanding of the natural history of advanced CKD.
For example, if the goal is for patients to undergo access
surgery 6 or 12 months prior to anticipated start of
maintenance dialysis, what should the corresponding
(estimated) glomerular filtration rate (GFR) threshold
be? Similarly, what is the likelihood of ESRD at a given
GFR level? To better understand these issues, we surveyed
nephrologists to better understand physician expectations
regarding preemptive AV access surgery. Then we examined
current preemptive AV fistula practice pattern at an
academic medical center and estimated, using a newly
developed equation, the likelihood of ESRD among patients
who actually underwent AV access surgery.
Methods
Survey of nephrologists
To explore clinical considerations and thresholds for
vascular access referral, we administered a voluntary and
anonymous short 8-question survey (Additional file 1) to
three populations of physicians: 1) full time academic
faculty members based at one of the three main University
of California at San Francisco (UCSF) teaching hospitals:
UCSF Medical Center, San Francisco Veterans Affairs
Medical Center and San Francisco General Hospital; 2)
community and academic nephrologists attending a
dinner presentation in San Diego in September, 2012 and
3) community and academic nephrologists attending an
annual medical directors’ meeting for a non-profit dialysis
company in September 2012. We excluded current fellows
in training. We collected demographic information about
the survey participants. Survey questions included: How
many months prior to the initiation of HD should an AV
fistula be created? At what estimated GFR should an AV
fistula be created? At what likelihood of ESRD within
1 year should an AV fistula be created? (Additional file 1).
Current preemptive vascular access creation practice pattern
Medical records for all consecutive patients seen by nine
attending physicians at the University of California at
San Francisco (UCSF) Medical Center Nephrology and
Hypertension Faculty Practices between July 1, 1999and December 31, 2010 were reviewed (N = 2995). We
identified 122 patients who underwent vascular access
creation (either AV fistula or AV graft). Of the 122, 6 were
excluded since they did not have follow-up information
within 1 year of vascular access placement, leaving a final
analytic sample of N = 116 (Figure 1). Information was
abstracted from clinic notes and electronic medical records
including: demographics, comorbidities and estimated
GFR (by the Modification of Diet in Renal Disease
study equation) [10]. All patients were followed for at least
one year following surgery.
Probability of ESRD according to prediction equation
As noted above, current guidelines mostly rely on a static
(estimated) GFR threshold or anticipated time to ESRD to
guide optimal timing of preemptive vascular access
surgery. It is possible that an alternative risk-score
based approach may be superior (i.e. preemptive vascular
access surgery will be recommended only for patients
whose likelihood of developing ESRD in the near future
exceeds a certain threshold). To explore this, we estimated
probability of ESRD using a recently published predictive
model by Tangri et al., among all 116 UCSF Medical Center
patients who underwent preemptive vascular access
placement [11].
Institutional review board approval from the UCSF




The results of the 3 surveys were remarkably consistent
(Table 1). Most nephrologists aimed to have preemptive
vascular access created about 6 months prior to start of
ESRD or when the chances of ESRD within the next year
Table 1 Survey of practicing nephrologists on timing of preemptive vascular access placement
UCSF Nephrologists San Diego nephrologists Medical directors
(N = 16) (N = 8) (N = 29)
Survey participant characteristics
Age, years, mean(SD) 46.1 (13.0) 43.1 (7.2) 51 (10.4)
Years in practice, median [IQR] 10.0 [2.0,21.0] 8.5 [6.0,12.0] 15.0 [10.0, 25.0]
Survey questions
“How many months before the initiation of hemodialysis
do you think an AV fistula should be created?” mean (SD)
6 (2) 6 (2) 6 (3)
“At what estimated GFR should an AV fistula be created?”
mean (SD)
18.0 (4.0) ml/min/1.73 m2 18.6 (3.8) ml/min/1.73 m2 17.5 (3.6) ml/min/1.73 m2
“Do you think that surgery to create an AV fistula should
be done when the likelihood of developing ESRD in the
next year is at or above”, % mean (SD)
67 (14)% 66 (19)% 68 (17) %
Bansal et al. BMC Nephrology 2013, 14:115 Page 3 of 6
http://www.biomedcentral.com/1471-2369/14/115is two-thirds or greater. The estimated GFR level at which
they believe match these conditions is approximately
18 ml/min/1.73 m2.Outcomes after preemptive vascular access placement
Among the 116 patients who underwent preemptive
vascular access creation at UCSF, the mean age was 64.3
(±14.5) and the mean estimated GFR was 16.1 (±6.8)
ml/min/1.73 m2 at the time of access creation (Table 2).
The vast majority of the patients underwent surgery for
AV fistula (N = 109; 94%) with the remainder undergoing
surgery for AV graft. In the year after surgery, only 57 out
of the 116 patients (49.1%) patients initiated maintenance
HD (Figure 1). There were no deaths. Mean time from
access placement to ESRD was 5 (±4) months. Patients
who initiated HD within 1 year were more likely to have
coronary heart disease (47% vs. 22%; p = 0.005) and had
lower estimated GFR level at the time of vascular access
construction (13.8 vs. 18.6 ml/min/1.73 m2; p < 0.001).Table 2 Baseline characteristics of patients with
preemptive vascular access placement at the time of access
construction at University of California, San Francisco
(N = 116)
Characteristic








Estimated GFR, mean (SD), ml/min/1.73 m2 * 16.1 (6.8)
AV Fistula (%) 94.0
AV Graft (%) 6.0
*calculated by the MDRD equation.There were no other obvious differences in co-morbid
conditions or etiology of CKD.
Probability of ESRD according to prediction equation
Among the 116 patients at UCSF who underwent AV
access surgery, the Tangri risk score could be calculated
only for 67 patients, as the rest never had their urine
albuminuria quantified (most had urine total protein
quantified instead). The mean and median time between
vascular access surgery and measurement of urine
albuminuria was 11.2 (17.9) months and 3.3 (IQR 1.3-13.4)
months, respectively, among the 67 patients. The calculated
2-year probability of ESRD was 61 ± 29% for patients
who in fact did develop ESRD within 1 year (N = 37)
and 33 ± 21% for the patients who did not develop
ESRD within 1 year (N = 30) (p < 0.001) (Table 3). Very
similar results were seen when we limit the comparison
to the 49 patients who have urine albumin quantified
within a year of the AV access surgery (also 61% vs. 34%,
p < 0.001) (Table 3).
Discussion
Our study contributes novel information to the literature
by quantifying the targets and expectations of practicing
nephrologists with regard to timing of preemptive AV
access surgery. Respondents to our surveys reveal that
they anticipate an estimated GFR of around 18 ml/min/
1.73 m2 is about 6 months prior to start of ESRD or
when the likelihood of ESRD within the next year is
more than two-thirds. We believe these data help us
understand the observed current preemptive AV access
surgery practice patterns—and why numerous patients
do not start dialysis within 12 months after surgery.
To our knowledge, prior to 2011, only two papers
examined rates of ESRD after preemptive creation of
dialysisAV access. O’Hare et al. investigated only U.S.
military veterans [12] and Weber et al. only Canadian
patients [13]. Since we initiated our study, two more
relevant papers have been published. Kimball et al.
Table 3 Predicted risk of ESRD among patients who did undergo pre-emptive AV access surgery
Hemodialysis within 1-year of AV
access surgery
Yes No
N = 37 N = 30
2-year risk of ESRD by Tangri equation in all patients with measured albuminuria (N = 67) Mean ± SD 61% ± 29% 33% ± 21%
Median (IQR) 66% (40% –83%) 28% (19% – 39%)
2-year risk of ESRD by Tangri equation in patients with albuminuria measured within 1 year
of vascular access surgery (N = 49)
N = 26 N = 23
Mean ± SD 61% ± 30% 34% ± 22%
Median (IQR) 65% (40%-84%) 28% (19%-38%)
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U.S. (Denver and Portland) [14] and Oliver et al. leveraged
a province-wide data base in Ontario, Canada [15]. Results
across these four published studies (O’Hare [12], Weber
[13], Kimball [14], Oliver [15]) and ours are quite similar.
The rate of initiating dialysis one year after preemptive AV
access surgery was 57% in O’Hare [12], 57% in Oliver [15],
and 49% at UCSF Medical Center (53% if PD were
counted). The mean estimated GFR at time of preemptive
AV access placement was 16.1 ml/min/1.73 m2 in our
study and 17.7 ml/min/1.73 m2 in the O’Hare study [12].
In the Kimball paper, 108 out of 150 of their patients had
stage 4 CKD at time of surgery (i.e. estimated GFR above
15 ml/min/1.73 m2). The study by Oliver et al. [15] did
not have information about estimated GFR at the time of
surgery. Estimated GFR at time of surgery was lower at
12 ml/min/1.73 m2 in the Canadian study by Weber
et al. and that study had a higher rate of start of dialysis
initiation after surgery (although their data were not
presented in a directly comparable manner).
Of note, the observed estimated GFR in the U.S.
studies—O’Hare, Kimball and ours--matches quite well
with what 3 different groups of U.S. nephrologists report
their target estimated GFR to be at the time of AV fistula
creation (~18 ml/min/1.73 m2) (Table 1).
One hypothesis which can explain these findings is that
many U.S. nephrologists do not have a good appreciation
of the natural history of disease in advanced CKD. We
consistently overestimate the estimated GFR level at which
dialysis is imminent. The goals of placing preemptive AF
fistulas as expressed by the nephrologists are to have this
procedure done about 6 months of starting dialysis, or
when the risk of ESRD is judged to be two-third or more
likely in the next year. That the relatively high estimated
GFR selected is not consistent with these targets is illus-
trated by the few natural history studies of advanced CKD
that exists. Levin et al. followed all CKD patient referred
to nephrology in the province of British Columbia who
had consistently low estimated GFR. Among those with
estimated GFR 15–24 ml/min (N = 1905, mean age 68 years
old), the cumulative risk of ESRD (receipt of dialysis or
transplant) was only 11% after one year [16]. Among thosewith estimated GFR < 15 (N = 647, mean age 67 y.o.)
the cumulative ESRD risk was only 32% after one year
[16]. Similarly, O’Hare documented in a comprehensive
national sample of U.S. veterans, that among in the
65–74 years old group, for those with estimated GFR
15–29 ml/min/1.73 m2, the one-year risk of ESRD was
only 9%. And even for those with estimated GFR < 15 ml/
min/1.73 m2, the one-year risk of ESRD was only 51%
(these rates do vary by age) [17].
Guideline writers and nephrologists may not appreciate
that the rate of loss of estimated GFR in advanced CKD
can often be very slow. In both the Levin and the O’Hare
studies, the median rate of decline of estimated GFR in
advanced CKD on the order of 2–3 ml/min/1.73 m2 per
year [12,16]. Elderly patients in particular have on average
slower progression by creatinine based estimated GFR.
Furthermore, many patients remain with stable (or even
improving) kidney function for months to years without
progression. Frequent non-linear estimated GFR trajectory
and non-progression has now clearly been documented
also at earlier stages of CKD [18].
We speculate that the targeting of a higher estimated
GFR threshold then that which matched anticipated
time to start of dialysis may have been influenced by the
wide promulgation of the NKF KDOQI CKD guidelines.
Since stage 5 CKD is labeled as “kidney failure,” some
may conflate estimated GFR of 15 ml/min/1.73 m2 as
being equivalent to imminent need for dialysis. This
notion may have been enforced by high profile studies
which designate estimated GFR < 15 ml/min/1.73 m2
without dialysis as being “untreated” “kidney failure” [19],
although recent initiatives by KDIGO have attempted to
distinguish between stage 5 requring dialysis versus stage
5 disease not requiring dialysis [20].
While one can debate whether or not having approxi-
mately half of the patients starting dialysis within one
year after AV access surgery is a high or low percentage,
this discussion does not diminish the conclusion that
nephrologists’ stated goals are internally inconsistent.
Unfortunately, it does not appear likely that the currently
best available prediction equation regarding risk of ESRD
will be directly helpful in guiding clinical decision making.
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(i.e. assessed 2-year risk of ESRD to patients who did go
on to receive hemodialysis within a year is higher than
the assessed risk for those who did not), the absolute
predicted risks are quite far from observed risks (the
two groups in Table 3 have actual observed 1-year risks
of 100% and 0%). This suboptimal performance means that
the equation cannot be introduced into clinical practice.
We believe that our results and the prior literature
point out the need for more studies to better understand
the natural history of advanced CKD. Unlike during earlier
phases of CKD, when management is unlike to change
substantially when GFR declines by 5 or 10 ml/min/
1.7 m2, during advanced CKD nephrologists must make
many important decisions over a relatively narrow range
of GFR. Missing the window for AV fistula creation is
certainly undesirable and this has been much emphasized
in the literature. Although this “window” may be later than
what has been generally practiced as earlier hemodialysis
start has not been associated with significant improvement
in cardiovascular events or survival [21,22]. Excessively
early placement is also not optimal since surgery incurs
pain and discomfort and risk of steal syndrome, high
output heart failure and other problems. Some patients
with advanced CKD would die without needing HD and
would have been better off not undergoing preemptive
vascular access surgery. A better understanding of the
natural history of CKD in generalizable populations, with
emphasis on understanding difference within particular
patient subgroups, will be key to improve practice patterns
and patient outcomes.
Our study had several strengths. We were able to study
the natural history of CKD from both the patient and
provider perspectives, which revealed inconsistencies in
the minds of nephrologists on timing of access placement
in relation to the natural history of progression of advanced
CKD. Detailed chart review was performed consistently by
a single senior nephrology fellow. Our study had some
limitations as well. Our survey sample size was small and
our survey was only administered to physicians practicing
in California. Our study focused on eGFR thresholds for
referral to vascular access placement, however we acknow-
ledge that proteinuria is a very important determinant
of renal prognosis. Our chart review study was based on
only one academic medical center and not large. In a
supplementary analysis, we also reviewed the charts of
all consecutive patients seen in the San Francisco Veterans
Affairs Medical Center Nephrology clinic between July 1,
2009 and June 30, 2010 (N = 199) and found similar
results. Over this time period, 20 patients underwent
preemptive vascular access creation (at mean estimated
GFR 21 ml/min/1.73 m2). Among them, only 7 (35%)
proceeded to HD within one year of vascular access
creation. One patient died prior to needing dialysis.More importantly, as described above, the estimated GFR
at the time of AV access surgery and the rates of ESRD
following surgery we noted are similar to findings from
other studies in diverse settings.
Conclusions
In conclusion, while opinion leaders continue to advocate
placement of AV fistulae at 20 ml/min/1.73 m2 [23], based
on everything we know so far, using this threshold will
result in surgery in many patients possibly years before
start of HD and will lead to unnecessary surgery procedures
in numerous patients who never progress to ESRD. A
more personalized approach is needed.
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